Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Intersect ENT, Inc.XENT · Entity 127294 | EVP & General Counsel | February 03, 2020 | February 05, 2020 |
| Pulmonx CorpLUNG · Entity 2359 | General Counsel | September 01, 2026 | September 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Intersect ENT, Inc.
Report date February 03, 2020 · Filed February 05, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 68,465 |
Reported balance
After 2020-02-03 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2020-02-03 · Grant · Acquired 10,740 · Balance 68,465 F1: Represents restricted stock units granted pursuant to the Intersect ENT, Inc. 2014 Equity Incentive Plan. Each restricted stock unit represents a right to receive one share of Intersect ENT, Inc. common stock upon vesting. The restricted stock units shall vest on the third anniversary from the date of grant provided that certain 30-day trailing average stock price (the "Average Closing Price") targets are achieved at any time during the three year period following the date of grant. 33 1/3%, 66 2/3% or 100% of the shares will vest if the Average Closing Price equals or exceeds specific stock price targets. F2: Includes 51,034 restricted stock units, of which 42,534 are performance based. |
| Common StockSEC Table I · non-derivative | Direct | 79,205 |
Reported balance
After 2020-02-03 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2020-02-03 · Grant · Acquired 10,740 · Balance 79,205 F3: Represents restricted stock units granted pursuant to the Intersect ENT, Inc. 2014 Equity Incentive Plan. Each restricted stock unit represents a right to receive one share of Intersect ENT, Inc. common stock upon vesting. The restricted stock units vest in three equal annual installments commencing one year after the grant date. F4: Includes 61,774 restricted stock units, of which 42,534 are performance based. |
| Stock Options (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $26.18 · Expires 2030-02-03 | Direct | 21,270 |
Reported balance
After 2020-02-03 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2020-02-03 · Grant · Acquired 21,270 · Balance 21,270 F5: The vesting commencement date of the option is February 3, 2020. 1/8th of the shares subject to the option shall vest on August 3, 2020 and 1/48th of the shares subject to the option shall vest monthly thereafter over 42 months. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units granted pursuant to the Intersect ENT, Inc. 2014 Equity Incentive Plan. Each restricted stock unit represents a right to receive one share of Intersect ENT, Inc. common stock upon vesting. The restricted stock units shall vest on the third anniversary from the date of grant provided that certain 30-day trailing average stock price (the "Average Closing Price") targets are achieved at any time during the three year period following the date of grant. 33 1/3%, 66 2/3% or 100% of the shares will vest if the Average Closing Price equals or exceeds specific stock price targets.
F2: Includes 51,034 restricted stock units, of which 42,534 are performance based.
F3: Represents restricted stock units granted pursuant to the Intersect ENT, Inc. 2014 Equity Incentive Plan. Each restricted stock unit represents a right to receive one share of Intersect ENT, Inc. common stock upon vesting. The restricted stock units vest in three equal annual installments commencing one year after the grant date.
F4: Includes 61,774 restricted stock units, of which 42,534 are performance based.
F5: The vesting commencement date of the option is February 3, 2020. 1/8th of the shares subject to the option shall vest on August 3, 2020 and 1/48th of the shares subject to the option shall vest monthly thereafter over 42 months.
Pulmonx Corp
Report date September 01, 2026 · Filed September 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 361,827 |
Ending reported balance
After 2026-09-01 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2026-09-01 · Sale · Disposed 3,807 · Balance 372,354 F1: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on March 1, 2023. Row 2 · 2026-09-01 · Sale · Disposed 2,224 · Balance 370,130 F2: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2024. Row 3 · 2026-09-01 · Sale · Disposed 3,476 · Balance 366,654 F3: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 3, 2025. Row 4 · 2026-09-01 · Sale · Disposed 4,827 · Balance 361,827 F4: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 2, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on March 1, 2023.
F2: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2024.
F3: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 3, 2025.
F4: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 2, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 01, 2026 Filed Sep 3, 2026 22:19 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 4,827 | $2.26 | $10,909.02 |
DisclosureSEC source: 0001354228-26-000005 · form4-09032026_100913.xml · nonDerivative · entry 4 Lehman David Aaron · CIK 0001354228 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 361,827 F4 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 2, 2026. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 22:19 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 3,476 | $2.26 | $7,855.76 |
DisclosureSEC source: 0001354228-26-000005 · form4-09032026_100913.xml · nonDerivative · entry 3 Lehman David Aaron · CIK 0001354228 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 366,654 F3 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 3, 2025. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 22:19 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 2,224 | $2.26 | $5,026.24 |
DisclosureSEC source: 0001354228-26-000005 · form4-09032026_100913.xml · nonDerivative · entry 2 Lehman David Aaron · CIK 0001354228 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 370,130 F2 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2024. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 22:19 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 3,807 | $2.26 | $8,603.82 |
DisclosureSEC source: 0001354228-26-000005 · form4-09032026_100913.xml · nonDerivative · entry 1 Lehman David Aaron · CIK 0001354228 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 372,354 F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on March 1, 2023. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:17 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 4,915 | $1.54 | $7,569.10 |
DisclosureSEC source: 0001354228-26-000003 · form4-06032026_080624.xml · nonDerivative · entry 4 Lehman David Aaron · CIK 0001354228 · GENERAL COUNSEL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 376,161 F4 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 2, 2026. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:17 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 3,539 | $1.54 | $5,450.06 |
DisclosureSEC source: 0001354228-26-000003 · form4-06032026_080624.xml · nonDerivative · entry 3 Lehman David Aaron · CIK 0001354228 · GENERAL COUNSEL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 381,076 F3 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 3, 2025. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:17 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 2,264 | $1.54 | $3,486.56 |
DisclosureSEC source: 0001354228-26-000003 · form4-06032026_080624.xml · nonDerivative · entry 2 Lehman David Aaron · CIK 0001354228 · GENERAL COUNSEL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 384,615 F2 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2024. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:17 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 3,876 | $1.54 | $5,969.04 |
DisclosureSEC source: 0001354228-26-000003 · form4-06032026_080624.xml · nonDerivative · entry 1 Lehman David Aaron · CIK 0001354228 · GENERAL COUNSEL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 386,879 F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on March 1, 2023. Read SEC document |
| March 02, 2026 Filed Mar 5, 2026 00:01 UTC | Pulmonx Corp LUNG · Entity 2359 | GrantCommon Stock | 150,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001354228-26-000002 · form4-03052026_120356.xml · nonDerivative · entry 5 Lehman David Aaron · CIK 0001354228 · GENERAL COUNSEL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 390,755 F5 · shares: Represents grant of RSUs payable solely in common stock of the Issuer that vest in equal quarterly installments over the four-year period from the grant date of March 2, 2026. Read SEC document |
| March 02, 2026 Filed Mar 5, 2026 00:01 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 4,051 | $1.43 | $5,792.93 |
DisclosureSEC source: 0001354228-26-000002 · form4-03052026_120356.xml · nonDerivative · entry 4 Lehman David Aaron · CIK 0001354228 · GENERAL COUNSEL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 240,755 F4 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 3, 2025. Read SEC document |
| March 02, 2026 Filed Mar 5, 2026 00:01 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 2,590 | $1.43 | $3,703.70 |
DisclosureSEC source: 0001354228-26-000002 · form4-03052026_120356.xml · nonDerivative · entry 3 Lehman David Aaron · CIK 0001354228 · GENERAL COUNSEL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 244,806 F3 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2024. Read SEC document |
| March 02, 2026 Filed Mar 5, 2026 00:01 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 4,433 | $1.43 | $6,339.19 |
DisclosureSEC source: 0001354228-26-000002 · form4-03052026_120356.xml · nonDerivative · entry 2 Lehman David Aaron · CIK 0001354228 · GENERAL COUNSEL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 247,396 F2 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2023. Read SEC document |
| March 02, 2026 Filed Mar 5, 2026 00:01 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 1,163 | $1.43 | $1,663.09 |
DisclosureSEC source: 0001354228-26-000002 · form4-03052026_120356.xml · nonDerivative · entry 1 Lehman David Aaron · CIK 0001354228 · GENERAL COUNSEL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 251,829 F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on March 1, 2022. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 00:43 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 3,401 | $1.57 | $5,339.57 |
DisclosureSEC source: 0001354228-25-000006 · form4-12042025_121229.xml · nonDerivative · entry 4 Lehman David Aaron · CIK 0001354228 · GENERAL COUNSEL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 252,992 F4 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 3, 2025. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 00:43 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 2,176 | $1.57 | $3,416.32 |
DisclosureSEC source: 0001354228-25-000006 · form4-12042025_121229.xml · nonDerivative · entry 3 Lehman David Aaron · CIK 0001354228 · GENERAL COUNSEL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 256,393 F3 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2024. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 00:43 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 3,725 | $1.57 | $5,848.25 |
DisclosureSEC source: 0001354228-25-000006 · form4-12042025_121229.xml · nonDerivative · entry 2 Lehman David Aaron · CIK 0001354228 · GENERAL COUNSEL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 258,569 F2 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2023. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 00:43 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 976 | $1.57 | $1,532.32 |
DisclosureSEC source: 0001354228-25-000006 · form4-12042025_121229.xml · nonDerivative · entry 1 Lehman David Aaron · CIK 0001354228 · GENERAL COUNSEL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 262,294 F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on March 1, 2022. Read SEC document |
| September 02, 2025 Filed Sep 3, 2025 21:08 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 3,231 | $1.60 | $5,169.60 |
DisclosureSEC source: 0001415889-25-023571 · form4-09032025_090929.xml · nonDerivative · entry 4 Lehman David Aaron · CIK 0001354228 · GENERAL COUNSEL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 263,270 F4 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 3, 2025. Read SEC document |
| September 02, 2025 Filed Sep 3, 2025 21:08 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 2,068 | $1.60 | $3,308.80 |
DisclosureSEC source: 0001415889-25-023571 · form4-09032025_090929.xml · nonDerivative · entry 3 Lehman David Aaron · CIK 0001354228 · GENERAL COUNSEL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 266,501 F3 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2024. Read SEC document |
| September 02, 2025 Filed Sep 3, 2025 21:08 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 3,541 | $1.60 | $5,665.60 |
DisclosureSEC source: 0001415889-25-023571 · form4-09032025_090929.xml · nonDerivative · entry 2 Lehman David Aaron · CIK 0001354228 · GENERAL COUNSEL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 268,569 F2 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2023. Read SEC document |
| September 02, 2025 Filed Sep 3, 2025 21:08 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 929 | $1.60 | $1,486.40 |
DisclosureSEC source: 0001415889-25-023571 · form4-09032025_090929.xml · nonDerivative · entry 1 Lehman David Aaron · CIK 0001354228 · GENERAL COUNSEL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 272,110 F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on March 1, 2022. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 22:02 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 3,283 | $3.13 | $10,275.79 |
DisclosureSEC source: 0001415889-25-015640 · form4-06042025_100644.xml · nonDerivative · entry 5 Lehman David Aaron · CIK 0001354228 · GENERAL COUNSEL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 273,039 F5 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 3, 2025. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 22:02 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 2,099 | $3.13 | $6,569.87 |
DisclosureSEC source: 0001415889-25-015640 · form4-06042025_100644.xml · nonDerivative · entry 4 Lehman David Aaron · CIK 0001354228 · GENERAL COUNSEL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 276,322 F4 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2024. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 22:02 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 3,597 | $3.13 | $11,258.61 |
DisclosureSEC source: 0001415889-25-015640 · form4-06042025_100644.xml · nonDerivative · entry 3 Lehman David Aaron · CIK 0001354228 · GENERAL COUNSEL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 278,421 F3 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2023. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 22:02 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 943 | $3.13 | $2,951.59 |
DisclosureSEC source: 0001415889-25-015640 · form4-06042025_100644.xml · nonDerivative · entry 2 Lehman David Aaron · CIK 0001354228 · GENERAL COUNSEL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 282,018 F2 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2022. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 22:02 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 535 | $3.14 | $1,679.90 |
DisclosureSEC source: 0001415889-25-015640 · form4-06042025_100644.xml · nonDerivative · entry 1 Lehman David Aaron · CIK 0001354228 · GENERAL COUNSEL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 282,961 F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on June 1, 2021. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 23:04 UTC | Pulmonx Corp LUNG · Entity 2359 | GrantCommon Stock | 108,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-007039 · form4-03052025_110343.xml · nonDerivative · entry 6 Lehman David Aaron · CIK 0001354228 · GENERAL COUNSEL 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 283,496 F7 · shares: Represents grant of RSUs payable solely in common stock of the Issuer that vest in equal quarterly installments over the four-year period from the grant date of March 3, 2025. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 23:04 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 13,622 | $7.97 | $108,567.34 |
DisclosureSEC source: 0001415889-25-007039 · form4-03052025_110343.xml · nonDerivative · entry 5 Lehman David Aaron · CIK 0001354228 · GENERAL COUNSEL 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 175,496 F5 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2024. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.88 to $8.23, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 23:04 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 2,397 | $7.14 | $17,114.58 |
DisclosureSEC source: 0001415889-25-007039 · form4-03052025_110343.xml · nonDerivative · entry 4 Lehman David Aaron · CIK 0001354228 · GENERAL COUNSEL 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 189,118 F4 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2024. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 23:04 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 4,490 | $7.14 | $32,058.60 |
DisclosureSEC source: 0001415889-25-007039 · form4-03052025_110343.xml · nonDerivative · entry 3 Lehman David Aaron · CIK 0001354228 · GENERAL COUNSEL 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 191,515 F3 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2023. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 23:04 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 1,177 | $7.14 | $8,403.78 |
DisclosureSEC source: 0001415889-25-007039 · form4-03052025_110343.xml · nonDerivative · entry 2 Lehman David Aaron · CIK 0001354228 · GENERAL COUNSEL 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 196,005 F2 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2022. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 23:04 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 669 | $7.14 | $4,776.66 |
DisclosureSEC source: 0001415889-25-007039 · form4-03052025_110343.xml · nonDerivative · entry 1 Lehman David Aaron · CIK 0001354228 · GENERAL COUNSEL 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 197,182 F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on June 1, 2021. Read SEC document |
| December 02, 2024 Filed Dec 4, 2024 23:16 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 1,610 | $6.18 | $9,949.80 |
DisclosureSEC source: 0001415889-24-028318 · form4-12042024_111215.xml · nonDerivative · entry 4 Lehman David Aaron · CIK 0001354228 · GENERAL COUNSEL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 197,851 F4 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2024. Read SEC document |
| December 02, 2024 Filed Dec 4, 2024 23:16 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 2,755 | $6.19 | $17,053.45 |
DisclosureSEC source: 0001415889-24-028318 · form4-12042024_111215.xml · nonDerivative · entry 3 Lehman David Aaron · CIK 0001354228 · GENERAL COUNSEL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 199,461 F3 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2023. Read SEC document |
| December 02, 2024 Filed Dec 4, 2024 23:16 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 722 | $6.19 | $4,469.18 |
DisclosureSEC source: 0001415889-24-028318 · form4-12042024_111215.xml · nonDerivative · entry 2 Lehman David Aaron · CIK 0001354228 · GENERAL COUNSEL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 202,216 F2 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2022. Read SEC document |
| December 02, 2024 Filed Dec 4, 2024 23:16 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 410 | $6.18 | $2,533.80 |
DisclosureSEC source: 0001415889-24-028318 · form4-12042024_111215.xml · nonDerivative · entry 1 Lehman David Aaron · CIK 0001354228 · GENERAL COUNSEL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 202,938 F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on June 1, 2021. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 22:08 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 1,688 | $6.69 | $11,292.72 |
DisclosureSEC source: 0001415889-24-022971 · form4-09052024_100923.xml · nonDerivative · entry 4 Lehman David Aaron · CIK 0001354228 · GENERAL COUNSEL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 203,348 F4 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2024. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 22:08 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 2,890 | $6.69 | $19,334.10 |
DisclosureSEC source: 0001415889-24-022971 · form4-09052024_100923.xml · nonDerivative · entry 3 Lehman David Aaron · CIK 0001354228 · GENERAL COUNSEL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 205,036 F3 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2023. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 22:08 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 758 | $6.69 | $5,071.02 |
DisclosureSEC source: 0001415889-24-022971 · form4-09052024_100923.xml · nonDerivative · entry 2 Lehman David Aaron · CIK 0001354228 · GENERAL COUNSEL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 207,926 F2 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2022. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 22:08 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 429 | $6.71 | $2,878.59 |
DisclosureSEC source: 0001415889-24-022971 · form4-09052024_100923.xml · nonDerivative · entry 1 Lehman David Aaron · CIK 0001354228 · GENERAL COUNSEL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 208,684 F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on June 1, 2021. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 21:59 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 1,603 | $6.97 | $11,172.91 |
DisclosureSEC source: 0001415889-24-015634 · form4-06052024_090644.xml · nonDerivative · entry 4 Lehman David Aaron · CIK 0001354228 · GENERAL COUNSEL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 209,113 F4 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2024. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 21:59 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 2,744 | $6.97 | $19,125.68 |
DisclosureSEC source: 0001415889-24-015634 · form4-06052024_090644.xml · nonDerivative · entry 3 Lehman David Aaron · CIK 0001354228 · GENERAL COUNSEL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 210,716 F3 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2023. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 21:59 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 719 | $6.97 | $5,011.43 |
DisclosureSEC source: 0001415889-24-015634 · form4-06052024_090644.xml · nonDerivative · entry 2 Lehman David Aaron · CIK 0001354228 · GENERAL COUNSEL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 213,460 F2 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2022. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 21:59 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 409 | $6.97 | $2,850.73 |
DisclosureSEC source: 0001415889-24-015634 · form4-06052024_090644.xml · nonDerivative · entry 1 Lehman David Aaron · CIK 0001354228 · GENERAL COUNSEL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 214,179 F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on June 1, 2021. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 23:18 UTC | Pulmonx Corp LUNG · Entity 2359 | GrantEmployee Stock Option (right to buy) · Derivative | 69,100 | $0.00 Strike: $9.30 | $0.00 |
DisclosureSEC source: 0001415889-24-006841 · form4-03052024_110357.xml · derivative · entry 5 Lehman David Aaron · CIK 0001354228 · GENERAL COUNSEL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,100 Underlying: Common Stock · 69,100 shares Expires 2034-02-28 F5 · derivative.exercise_date: The shares subject to the option vest in 48 equal monthly installments beginning on March 1, 2024. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 23:18 UTC | Pulmonx Corp LUNG · Entity 2359 | GrantCommon Stock | 34,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-006841 · form4-03052024_110357.xml · nonDerivative · entry 4 Lehman David Aaron · CIK 0001354228 · GENERAL COUNSEL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 179,988 F4 · shares: Represents grant of RSUs payable solely in common stock of the Issuer that vest over four years in equal quarterly installments beginning on March 1, 2024. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 23:18 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 3,083 | $9.06 | $27,931.98 |
DisclosureSEC source: 0001415889-24-006841 · form4-03052024_110357.xml · nonDerivative · entry 3 Lehman David Aaron · CIK 0001354228 · GENERAL COUNSEL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 145,488 F3 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2023. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 23:18 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 809 | $9.06 | $7,329.54 |
DisclosureSEC source: 0001415889-24-006841 · form4-03052024_110357.xml · nonDerivative · entry 2 Lehman David Aaron · CIK 0001354228 · GENERAL COUNSEL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 148,571 F2 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2022. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 23:18 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 459 | $9.06 | $4,158.54 |
DisclosureSEC source: 0001415889-24-006841 · form4-03052024_110357.xml · nonDerivative · entry 1 Lehman David Aaron · CIK 0001354228 · GENERAL COUNSEL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 149,380 F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on June 1, 2021. Read SEC document |
| March 01, 2024 Filed Mar 8, 2024 00:54 UTC Amendment | Pulmonx Corp LUNG · Entity 2359 | GrantEmployee Stock Option (right to buy) · Derivative | 34,500 | $0.00 Strike: $9.30 | $0.00 |
DisclosureSEC source: 0001415889-24-007230 · form4a-03082024_120320.xml · derivative · entry 2 Lehman David Aaron · CIK 0001354228 · GENERAL COUNSEL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,500 Underlying: Common Stock · 34,500 shares Expires 2034-02-28 F2 · derivative.exercise_date: The shares subject to the option vest in 48 equal monthly installments beginning on March 1, 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.